Home/STAb Therapeutics/Belén Blanco

BB

Belén Blanco

Chief Scientific Officer

STAb Therapeutics

Therapeutic Areas

Oncology Hematological Malignancies

STAb Therapeutics Pipeline

Drug	Indication	Phase
STAb-T19	Relapsed/Refractory CD19+ B-cell malignancies (e.g., B-ALL, B-cell lymphomas)	Pre-clinical

Leadership Team at STAb Therapeutics

Chief Executive Officer

View full STAb Therapeutics profile